Hubei Hongyuan Pharmaceutical Technology Co., Ltd. Stock
Equities
301246
CNE100005ZB9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.6 CNY | -0.29% | +2.64% | -47.65% |
Sales 2022 | 2.06B 284M | Sales 2023 | 2.05B 283M | Capitalization | 10.39B 1.43B |
---|---|---|---|---|---|
Net income 2022 | 435M 59.84M | Net income 2023 | 87M 11.97M | EV / Sales 2022 * | - |
Net cash position 2022 | 51.05M 7.02M | Net cash position 2023 | 1.83B 252M | EV / Sales 2023 | 4.17 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
116
x | Employees | 2,075 |
Yield 2022 * |
-
| Yield 2023 |
0.19% | Free-Float | 37.32% |
1 day | -0.29% | ||
1 week | +2.64% | ||
Current month | +1.04% | ||
1 month | -11.63% | ||
3 months | -23.98% | ||
6 months | -47.57% | ||
Current year | -47.65% |
Managers | Title | Age | Since |
---|---|---|---|
Shuang Xi Xu
CEO | Chief Executive Officer | 58 | - |
Gao Liang Lei
CHM | Chairman | 59 | - |
Ke Feng Zeng
DFI | Director of Finance/CFO | 39 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Shou Ying Du
BRD | Director/Board Member | 64 | - |
Zhi Hua Deng
BRD | Director/Board Member | 54 | - |
Guo Ping Yin
FOU | Founder | 64 | 02-01-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-03 | 13.6 | -0.29% | 2,031,239 |
24-07-02 | 13.64 | +0.44% | 1,802,747 |
24-07-01 | 13.58 | +0.89% | 2,271,899 |
24-06-28 | 13.46 | -0.22% | 2,156,600 |
24-06-27 | 13.49 | -2.03% | 2,499,706 |
End-of-day quote Shenzhen S.E., July 02, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-47.65% | 750M | |
+54.07% | 816B | |
+38.59% | 634B | |
-7.05% | 351B | |
+15.44% | 323B | |
+5.72% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B |
- Stock Market
- Equities
- 301246 Stock